Innovative Solutions in Pre-Filled Syringes for Biologics and Ophthalmic Applications

July 11th, 2024 – 4pm (CET) / 10am (ET)

Innovative Solutions in Pre-Filled Syringes for Biologics and Ophthalmic Applications

July 11th, 2024 – 4pm (CET) / 10am (ET)

Addressed Challenges

1) Streamline the integration of the primary drug containers and delivery systems

Early-stage analytical services can facilitate the selection of the right drug containment solution (DCS) and drug delivery system (DDS) to assess complete compatibility. The benefits allow to select optimal DCS and DDS to speed up the decision-making process and time to market which is crucial for new products.

2) Tackling Biologics – complex, sensitive and hard-to-stabilize drugs

Plasma treatment on prefillable syringes ensures exceptional stability and resilience over-time. This advanced coating is the perfect match for a broad range of applications for Biologics including ophthalmology, monoclonal antibody and mRNA and viral vector products requiring cold-temperature storage.

3) Acceleration of therapy moving from hospital to home care, driving adoption of drug delivery systems

Accurate barrel dimensions & tolerances are crucial for device integration as they can impact functionality. In the webinar we will speak about how to assure compatibility with new generation and commercially available auto-injectors.

4) Increased concentration of biologic formulations lead to higher viscosity solutions which are challenging to deliver accurately.

We will find out how to overcome viscosity challenges thanks to syringe options with increased internal needle diameter.

 

Learning Objectives

  • Analytical services can simplify the journey of combination products from early-stage design, all the way through launch
  • Specialized PFS syringes meet the key requirements of protein-based or high viscosity drugs
  • Auto-injectors which help patient centricity and ease of use are dependent on specialized primary containers

Enrico Barichello

Product Manager, Syringe Platform – DCS Glass, Stevanato Group

Enrico Barichello acquired broad-spectrum skills in technical concepts and complex processes. He joined Stevanato Group in 2017 as a Product Management Specialist for the Syringe platform. He defined and coordinated all the activities required to bring the products to market, bridging gaps between different company functions and aligning the involved teams. He has been responsible for the roadmap and execution of the innovative platform Alba®. Since 2023 he is Product Manager for the Glass Syringe Platform.
Read More >>>

Alan Xu

Product Manager for Analytical Services, Stevanato Group

Alan Xu is Stevanato Group’s Product Manager for Analytical Services and has been with the company since 2019. He is a primary contact for pharmaceutical and contract organizations around the world who are interested in leveraging TEC’s expertise to de-risk and optimize their combination products. Alan also investigates new analytical opportunities like low temperature CCIT and promotes awareness on ways to improve product quality and patient safety using data-driven methods. Prior to Stevanato Group, he was an Engineering Manager leading the development and pilot production of a novel primary container for a novel auto-injector specializing in biologics. He holds a degree in Mechanical Engineering from the Massachusetts Institute of Technology (MIT).
Read More >>>

<span>By ticking this box, you agree to the privacy policy of <a href=”https://www.stevanatogroup.com/it/privacy-policy/” style=”color:white; text-decoration: underline;” target=”_blank”>Stevanato Group</a> consenting to receiving communications related to this topic and other products or services within their portfolio</span>

Dark